U.S. Department of Health and Human Services: Rural Communities Opioid Response Program – Planning
The purpose of Rural Communities Opioid Response Program-Planning (RCORP-Planning) is to support treatment for and prevention of substance use disorder, including opioid use disorder (OUD), in rural counties at the highest risk for substance use disorder. The overall goal of RCORP-Planning is to reduce the morbidity and mortality associated with opioid overdoses in high-risk rural communities by multi-sector consortiums planning to strengthen their organizational and infrastructural capacity to address one or more of the following focus areas at the community, county, state, and/or regional levels:
- Prevention: Reducing the occurrence of opioid use disorder among new and at-risk users, as well as fatal opioid-related overdoses, through activities such as community and provider education, and harm reduction measures including the strategic placement and use of overdose reversing devices, such as naloxone and syringe services programs
- Treatment: Implementing or expanding access to evidence-based practices for opioid addiction/OUD treatment, such as medication-assisted treatment (MAT) including developing strategies to eliminate or reduce treatment costs to uninsured and underinsured patients
- Recovery: Expanding peer recovery and treatment options that help people start and stay in recovery
The program is part of a multi-year opioid-focused effort that will include: improving access to and recruitment of new substance use disorder providers; building sustainable treatment resources; increasing the use of telehealth; establishing cross-sector community partnerships; implementing new models of care, including integrated behavioral health; and providing technical assistance.
RCORP-Planning award recipients are encouraged to cultivate strong county, state, and regional-level consortiums and to incorporate workforce recruitment and retention needs and efforts into planning and capacity building activities throughout the period of performance. For example, RCORP-Planning award recipients can use funds to ensure that health care organizations obtain eligibility for placement of rural National Health Service Corps (NHSC) clinicians in future years.
These consortiums should work toward becoming operational and sustainable beyond the project year, and achieving levels of efficiency and service integration and coordination to implement multi-county or state OUD prevention, treatment, and recovery initiatives. It is expected that consortiums will develop plans to ensure that services provided to the target population are affordable and accessible. Therefore, RCORP-Planning award recipients are also encouraged to leverage and coordinate their OUD activities with other federal, state, and local OUD resources during the period of performance.
Amount: A total of $24,000,000 is available to award up to 120 grants that range up to $200,000 each.
Eligibility: Domestic public or private, non-profit or for-profit, entities, including faith-based and community-based organizations, tribes, and tribal organizations, who will serve rural communities at the highest risk for substance use disorder, who meet the RCORP-Planning specifications for the applicant organization and consortium as described below.
Applicant organization specifications: The applicant organization may be located in an urban or rural area, but all activities supported by this program must exclusively target populations residing in HRSA-designated rural counties or rural census tracts in urban counties and the consortium overall must be representative of rural entities. The applicant organization should have the staffing and infrastructure necessary to oversee program activities, serve as the fiscal agent for the grant, and ensure that local control for the grant is vested in the target rural communities. If the applicant organization is an urban entity, at least two consortium members involved in the proposed project must be located in HRSA-designated rural counties or rural census tracts in urban counties. To ascertain whether a particular county or census tract is rural, refer to http://datawarehouse.hrsa.gov/RuralAdvisor/.
Consortium specifications: The applicant organization must be part of a group of entities that have committed to forming a consortium or are part of an established consortium. For the purposes of this program, a consortium is defined as an organizational arrangement among four or more separately owned domestic public or private entities, including the applicant organization. The applicant organization, along with each consortium member who will receive any of the awarded funds, must have separate and different Employer Identification Numbers (EINs). Consortium members should come from multiple sectors and disciplines. Consortium members may be located in urban or rural areas, but all activities supported by this program must exclusively target populations residing in HRSA-designated rural counties or rural census tracts in urban counties and the consortium overall must be representative of rural entities. To ascertain whether a particular county or census tract is rural, refer to http://datawarehouse.hrsa.gov/RuralAdvisor/.
Examples of potential consortium members include, but are not limited to:
- Health care providers
- HIV and HCV prevention organizations
- Single State Agencies (SSAs)
- Primary Care Offices
- State Offices of Rural Health
- Law enforcement
- Emergency Medical Services entities
- School systems
- Primary Care Associations
- Poison control centers
- Maternal, Infant, and Early Childhood Home Visiting Program local implementing agencies
- Healthy Start sites
- Other social service agencies and organizations
Additional eligibility information: Appendix A of the solicitation gives a listing of eligible counties, but an applicant does not have to be listed in one of the listed counties to be eligible for this opportunity (no New Mexico counties are listed). All rural-communities at high-risk for substance use disorder are eligible to apply so long as they meet the programmatic and eligibility criteria. The counties listed in this Appendix reflect only those that were identified by CDC as being at risk for HIV and Hepatitis C infections due to injection drug use.
This post was filed under: